HK1188608A1 - Dna expression construct dna - Google Patents

Dna expression construct dna

Info

Publication number
HK1188608A1
HK1188608A1 HK14101581.7A HK14101581A HK1188608A1 HK 1188608 A1 HK1188608 A1 HK 1188608A1 HK 14101581 A HK14101581 A HK 14101581A HK 1188608 A1 HK1188608 A1 HK 1188608A1
Authority
HK
Hong Kong
Prior art keywords
dna
expression construct
dna expression
construct dna
expression
Prior art date
Application number
HK14101581.7A
Other languages
English (en)
Chinese (zh)
Inventor
Matthias Schroff
Christiane Kleuss
Kerstin Kapp
Original Assignee
Mologen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43598917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1188608(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mologen Ag filed Critical Mologen Ag
Publication of HK1188608A1 publication Critical patent/HK1188608A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/24—Vectors characterised by the absence of particular element, e.g. selectable marker, viral origin of replication

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
HK14101581.7A 2010-12-23 2014-02-19 Dna expression construct dna HK1188608A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1021873.3A GB201021873D0 (en) 2010-12-23 2010-12-23 DNA expression construct
PCT/EP2011/073984 WO2012085282A1 (en) 2010-12-23 2011-12-23 Dna expression construct

Publications (1)

Publication Number Publication Date
HK1188608A1 true HK1188608A1 (en) 2014-05-09

Family

ID=43598917

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14101581.7A HK1188608A1 (en) 2010-12-23 2014-02-19 Dna expression construct dna

Country Status (20)

Country Link
US (1) US20130287814A1 (xx)
EP (1) EP2655620B1 (xx)
JP (2) JP6377349B2 (xx)
KR (1) KR101517365B1 (xx)
CN (1) CN103370413B (xx)
AU (1) AU2011347086B2 (xx)
BR (1) BR112013015819A2 (xx)
CA (1) CA2822367A1 (xx)
DK (1) DK2655620T3 (xx)
ES (1) ES2549192T3 (xx)
GB (1) GB201021873D0 (xx)
HK (1) HK1188608A1 (xx)
IL (1) IL227104A (xx)
MX (1) MX343699B (xx)
PL (1) PL2655620T3 (xx)
PT (1) PT2655620E (xx)
RU (1) RU2604186C2 (xx)
SG (1) SG191327A1 (xx)
WO (1) WO2012085282A1 (xx)
ZA (1) ZA201304998B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021873D0 (en) * 2010-12-23 2011-02-02 Mologen Ag DNA expression construct
US10434064B2 (en) 2014-06-04 2019-10-08 Exicure, Inc. Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
EP3220895B1 (en) 2014-11-21 2022-08-31 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) * 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
US11433131B2 (en) 2017-05-11 2022-09-06 Northwestern University Adoptive cell therapy using spherical nucleic acids (SNAs)
EP3854419A1 (en) * 2020-01-24 2021-07-28 Univerzita Karlova, Lekarska fakulta v Plzni Dna conjugate and method of transformation of genes into cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2138553C1 (ru) * 1991-09-30 1999-09-27 Берингер Ингельгейм Интернациональ ГмбХ Трансфекционная композиция для высших эукариотных клеток, комплекс нуклеиновой кислоты, пригодный в качестве компонента трансфекционной композиции, конъюгат, пригодный в качестве компонента трансфекционной композиции, эндосомолитический пептид, пригодный в качестве компонента трансфекционной композиции
TW480282B (en) * 1996-04-24 2002-03-21 Ren Wen Corp Recombinant eucaryotic vector containing allergen gene and use of preventing and treating allergic disease thereof
DE19648625A1 (de) * 1996-11-13 1998-05-14 Soft Gene Gmbh Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
US20030157717A1 (en) * 2001-09-07 2003-08-21 Baylor College Of Medicine Texas Medical Center Linear DNA fragments for gene expression
DE50306394D1 (de) * 2002-07-19 2007-03-15 Mologen Ag Dna-expressionskonstrukt zur multiplen genexpression
AU2004320986A1 (en) * 2004-06-23 2006-01-05 Usv Limited Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
WO2009035554A2 (en) * 2007-09-07 2009-03-19 University Of Florida Research Foundation, Inc. Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem
GB201021873D0 (en) * 2010-12-23 2011-02-02 Mologen Ag DNA expression construct

Also Published As

Publication number Publication date
JP2014508512A (ja) 2014-04-10
PT2655620E (pt) 2015-10-26
IL227104A (en) 2017-02-28
MX343699B (es) 2016-11-16
WO2012085282A1 (en) 2012-06-28
ES2549192T3 (es) 2015-10-23
ZA201304998B (en) 2014-03-26
KR20130107350A (ko) 2013-10-01
AU2011347086A1 (en) 2013-07-25
JP2018007669A (ja) 2018-01-18
EP2655620A1 (en) 2013-10-30
PL2655620T3 (pl) 2016-01-29
DK2655620T3 (en) 2015-11-09
RU2013132149A (ru) 2015-01-27
US20130287814A1 (en) 2013-10-31
CN103370413A (zh) 2013-10-23
CA2822367A1 (en) 2012-06-28
KR101517365B1 (ko) 2015-05-06
MX2013007285A (es) 2013-09-26
CN103370413B (zh) 2016-06-01
RU2604186C2 (ru) 2016-12-10
SG191327A1 (en) 2013-07-31
EP2655620B1 (en) 2015-08-12
AU2011347086B2 (en) 2015-07-16
GB201021873D0 (en) 2011-02-02
JP6377349B2 (ja) 2018-08-22
BR112013015819A2 (pt) 2018-05-29

Similar Documents

Publication Publication Date Title
IL231983A0 (en) Dna containing tricyclo-phosphorothioate
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
IL226299A (en) Oligonucleotides that stimulate the immune system
EP2566479A4 (en) AZA-INDAZOLES
GB201205984D0 (en) No details
EP2640189A4 (en) 3-deutero-pomalidomide
GB201112400D0 (en) No details
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2651505A4 (en) ELECTROPORATION-INDUCED ELECTROSENSIBILIZATION
HK1188608A1 (en) Dna expression construct dna
EP2641891A4 (en) PKC ACTIVATOR-
GB2479833B (en) Modified nucleotides
HK1179567A1 (en) Pipette
GB201202348D0 (en) No details
GB201105908D0 (en) No details
GB201009658D0 (en) Incubator
AU4536P (en) TB01 Tibouchina urvilleana
AU4937P (en) FlatinsulGL Myoporum insulare
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum
AU4932P (en) FlatwaxpinkGL Chamelaucium uncinatum
ZA201104652B (en) Novel expression construct
GB201021720D0 (en) Gene variant
GB201010471D0 (en) Gene variant

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191220